Shares of Clorox Company (The) (NYSE:CLX) have received an average rating of “Hold” from the fourteen research firms that are presently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $125.42.

Several research firms have recently commented on CLX. Jefferies Group LLC restated a “hold” rating and issued a $137.00 price target (up previously from $136.00) on shares of Clorox Company (The) in a report on Wednesday, August 9th. Zacks Investment Research lowered shares of Clorox Company (The) from a “hold” rating to a “sell” rating in a report on Wednesday. Royal Bank Of Canada restated a “hold” rating and issued a $115.00 price target on shares of Clorox Company (The) in a report on Wednesday, August 2nd. BMO Capital Markets restated a “buy” rating and issued a $150.00 price target on shares of Clorox Company (The) in a report on Thursday. Finally, BidaskClub upgraded shares of Clorox Company (The) from a “strong sell” rating to a “sell” rating in a report on Monday, July 31st.

ILLEGAL ACTIVITY NOTICE: “Clorox Company (The) (CLX) Receives $123.47 Average PT from Analysts” was published by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this article can be viewed at https://www.watchlistnews.com/clorox-company-the-clx-receives-123-47-average-pt-from-analysts/1613917.html.

Shares of Clorox Company (CLX) traded up 0.14% during midday trading on Friday, reaching $129.14. 1,096,307 shares of the company’s stock were exchanged. The company has a market cap of $16.67 billion, a price-to-earnings ratio of 24.21 and a beta of 0.39. The stock’s 50 day moving average price is $134.59 and its 200 day moving average price is $134.61. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating the consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. During the same quarter in the previous year, the business posted $1.30 EPS. The company’s quarterly revenue was up 2.9% compared to the same quarter last year. Equities analysts anticipate that Clorox Company will post $5.66 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 13th. Investors of record on Wednesday, October 25th will be paid a dividend of $0.84 per share. The ex-dividend date is Tuesday, October 24th. This represents a $3.36 annualized dividend and a dividend yield of 2.60%. Clorox Company (The)’s dividend payout ratio (DPR) is presently 63.04%.

In other Clorox Company (The) news, EVP James E. Foster sold 9,861 shares of the business’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the sale, the executive vice president now owns 22,069 shares of the company’s stock, valued at approximately $3,056,777.19. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, COO Dawn C. Willoughby sold 2,158 shares of the business’s stock in a transaction that occurred on Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total transaction of $297,804.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 21,242 shares of company stock worth $2,944,449. 1.00% of the stock is owned by insiders.

A number of large investors have recently added to or reduced their stakes in CLX. BlackRock Inc. grew its position in Clorox Company (The) by 1,402.2% during the 1st quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock worth $1,400,912,000 after purchasing an additional 9,698,542 shares during the last quarter. Janus Henderson Group PLC grew its position in Clorox Company (The) by 8,008.5% during the 2nd quarter. Janus Henderson Group PLC now owns 1,323,475 shares of the company’s stock worth $176,340,000 after purchasing an additional 1,307,153 shares during the last quarter. Vanguard Group Inc. grew its position in Clorox Company (The) by 4.8% during the 1st quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock worth $1,909,829,000 after purchasing an additional 649,766 shares during the last quarter. Ameriprise Financial Inc. grew its position in Clorox Company (The) by 24.6% during the 2nd quarter. Ameriprise Financial Inc. now owns 1,341,272 shares of the company’s stock worth $178,433,000 after purchasing an additional 265,200 shares during the last quarter. Finally, Renaissance Technologies LLC grew its position in Clorox Company (The) by 24.5% during the 2nd quarter. Renaissance Technologies LLC now owns 1,341,400 shares of the company’s stock worth $178,728,000 after purchasing an additional 263,700 shares during the last quarter. 71.33% of the stock is currently owned by institutional investors.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.